Related Experiment Video
Updated: Oct 2, 2026

High-throughput Screening for Broad-spectrum Chemical Inhibitors of RNA Viruses
Published on: May 5, 2014
A Temporal Interactome Atlas across RNA Viruses reveals Convergent Vulnerabilities for Antiviral Repurposing
Abstract:
Viruses remodel host protein interactions to facilitate their replication, yet these dynamic interactomes remain largely unmapped and difficult to compare across infections. Here, to facilitate comparative virology studies, we build the Interactome and Viral Infection Dynamics (InterVir) Atlas, performing thermal proximity coaggregation to profile temporal interactome remodeling across five major RNA viral pathogens. We develop PROTEA, an AI framework that quantifies interactome homology and identifies convergent regulatory hubs. Infection-specific signatures include neuronal SHC1 rewiring associated with altered measles virus replication and dengue-specific secretase interactomes linked to cell-junction remodeling. Comparative virology analyses uncover unexpected interactome convergence between measles and flaviviruses, unobserved in protein-abundance profiling. Mapping these shared regulatory programs to drug targets allowed prioritization of compound repurposing as antivirals. Experimental testing of ten compounds demonstrated antiviral efficacy across multiple infections. Together, InterVir and PROTEA establish an open-access resource for comparative virology, facilitating the identification of conserved host vulnerabilities and drug repurposing.
More Related Videos
Related Concept Videos
Viruses with RNA Genomes
Leaky Scanning
Inhibitors Of Virion Release
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Retrovirus Life Cycles

